Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy

Affiliations

• ¹ Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
• ² Division of Biostatistics, Institute of Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
• ³ Center for Immunology, Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
• ⁴ Medical College of Wisconsin Medical School, Milwaukee, WI, USA.
• ⁵ Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁶ Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁷ Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA, USA.
• ⁸ Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. andsouza@mcw.edu.